BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7035869)

  • 21. Competition between tuftsin and HBV S-protein sequences.
    Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
    Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
    Martinez J; Winternitz F
    Ann N Y Acad Sci; 1983; 419():23-34. PubMed ID: 6585171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuftsin].
    Mücke D
    Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
    Najjar VA
    Exp Cell Biol; 1978; 46(1-2):114-26. PubMed ID: 579629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH; Babcock GF; Nishioka K
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
    Buchta R; Fridkin M; Pontet M; Romeo D
    Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.
    Bump NJ; Najjar VA
    Mol Cell Biochem; 1984 Sep; 63(2):137-42. PubMed ID: 6493218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific translocation of tuftsin (Thr-Lys-Pro-Arg), a natural immunomodulating peptide, into the nuclei of human monocytes.
    Wagle JR; Ansevin AT; Dessens SE; Nishioka K
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1147-53. PubMed ID: 2494998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative assessment of tuftsin receptor expression and second messenger during in vitro differentiation of peripheral blood derived monocytes of leprosy patients.
    Khare S; Bhutani LK; Rao DN
    Mol Cell Biochem; 1997 Jun; 171(1-2):1-10. PubMed ID: 9201689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ; Słoń J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and biochemical characteristics of the tetrapeptide tuftsin, Thr-Lys-Pro-Arg.
    Najjar VA
    Adv Exp Med Biol; 1979; 121(A):131-47. PubMed ID: 398141
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
    Paradowski A; Dynowski Z; Kubik A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stimulation of oxygen metabolism in human blood phagocytes as affected by tuftsin-like peptides derived from the C-reactive protein molecule].
    Polevshchikov AV; Nazarov PG
    Biull Eksp Biol Med; 1993 Jan; 115(1):55-6. PubMed ID: 8054580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
    Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
    Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The generation of antibody in mice to tuftsin: a naturally occurring phagocytosis stimulating tetrapeptide.
    Naim JO; van Oss CJ
    Immunol Invest; 1991 Jul; 20(4):351-64. PubMed ID: 1937582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subjects.
    Spirer Z; Zakuth V; Bogair N; Fridkin M
    Eur J Immunol; 1977 Feb; 7(2):69-74. PubMed ID: 577481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.